Business & Industry

Pharmexcil puts Nigeria subsidised warehouse facility plan on hold

Plans by India’s Pharmaceutical Export Promotion Council of India (Pharmexcil) to set up an exclusive warehousing facility for Indian pharmaceutical products in Nigeria is yet to take off with many of the member exporters of the Council are understood to have not paid the commitment fees for the project, reports Pharmabiz. Pharmexcil, with the support of

May & Baker to raise new expansion capital

MAY & BAKER Nigeria Plc has indicated that it plans to raise additional capital to support its business expansion and steady the healthcare company against competition, and is currently considering various ways of raising the new capital.

Pharmexcil puts Nigeria subsidised warehouse facility plan on hold

Plans by India’s Pharmaceutical Export Promotion Council of India (Pharmexcil) to set up an exclusive warehousing facility for Indian pharmaceutical products in Nigeria is yet to take off with many of the member exporters of the Council are understood to have not paid the commitment fees for the project, reports Pharmabiz. Pharmexcil, with the support of

Deals

Policy & Regulatory Affairs

NEPAD establishes centres of excellence to help strengthen regulatory capacity development

Following the New Partnership for Africa’s Development (NEPAD) Planning and Coordinating Agency’s call for expression of interest in establishing Regional Centres of Regulatory Excellence (RCOREs), the African Medicines Regulatory Harmonisation (AMRH) Programme has announced that 10 academic institution or partnership of institutions and National Medicines Regulatory Authorities (NMRAs) with specific regulatory science expertise as well as

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Manufacturing & Production

Swipha receives WHO GMP certification

Swiss Pharma Nigeria Limited (Swipha) made history recently as the first company to receive World Health Organisation (WHO) Good Manufacturing Practice (GMP) Certification in West Africa. WHO granted the certification after an extensive review and audit of the establishment’s manufacturing and laboratory facilities.

Big Pharma may threaten to cut S.Africa investment in generics row

Global drug firms may threaten to cut their South African investments as part of a campaign against Pretoria’s plans to overhaul its intellectual property laws to favour generic production, documents seen by Reuters show. South Africa is in the final stages of implementing a new law that would allow generic drugmakers to produce cut-price copies

Pfizer, South African University in Research Partnership

US pharmaceutical giant Pfizer is set to partner with South Africa’s North-West University in preclinical research, a key field in the development of new drugs, following the signing of a memorandum of understanding between the company and the university this week.

Pharma Projects

Hikma Pharma Signs JV Agreement With MIDROC Pharma; eyes Africa growth

Hikma Pharmaceuticals Plc, multinational pharmaceutical group, announced Wednesday that it has signed a 50:50 joint venture agreement with MIDROC Pharmaceuticals Limited, a member of Sheikh Mohammed Hussein Al Amoudi’s MIDROC Group, to establish a presence in the Ethiopian pharmaceutical market. The joint venture will be called HikmaCure.

Plans set for new ARV production plant in Ghana

Oxford International Biomedical Ventures (OIBV), the ‘commercial arm’ of  United Kingdom-based charitable organisation Oxford International Biomedical Centre (OIBC) and the Government of Ghana (GoG) led by the Ministry of Environment, Science and Technology (MEST), are set to jointly establish a plant to manufacture anti-retroviral drugs and drugs for Priority Endemic Diseases in Ghana, OIBC said in a

People

Press Releases

Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia

•          One million antimalarial treatments donated by Novartis, matching one million treatments funded through Malaria No More’s Power of One campaign •          Power of One enables the public to fund malaria tests and treatments for children in Africa through online and mobile technology •          Today marks World Health Day, focusing on vector-borne diseases, of which

International

Cipla acquires 51% stake in Yemeni company

Drugmaker Cipla on Monday announced that it would acquire a 51% stake in a pharmaceuticals’ manufacturing and distribution business in Yemen for $21 million. Cipla, India’s fifth largest pharmaceutical company in terms of revenue, did not disclose the name of the company in which it is acquiring the majority stake, only indicating that the target firm

China delegation conducts East African visit and seminar

The Chinese Chamber of Commerce for Import & Export of Medicines and Health Products (CCCMHPIE) last month led a delegation to the East African countries of Kenya and Tanzania from Sep. 13 to 19 during which it held in Kenya a seminar titled “Sino-Africa Drug Trade Cooperation – The Seminar on Chinese Medicinal Products”.

Top
Follow

Get every new post delivered to your Inbox

Join other followers